| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Froimson Mark is a Director at Pacira BioSciences, Inc.. Recent SEC Form 4 filings include 2 buys and 2 sells.
Estimated insider holdings value: $480K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | PCRX Pacira Biosciences, Inc. | Director | Buy | 1,400 | $11.58 | $16,212.00 | +10.7% | +42.4% | +101.9% | |
| May 9, 2022 | PCRX Pacira Biosciences, Inc. | Director | Sell | 1,000 | $59.37 | $59,370.00 | -16.9% | -1.7% | -28.3% | |
| Mar 15, 2021 | PCRX Pacira Biosciences, Inc. | Director | Sell | 734 | $72.26 | $53,038.84 | -12.3% | -17.2% | -2.6% | |
| Aug 8, 2017 | PCRX Pacira Biosciences, Inc. | Director | Buy | 100 | $37.13 | $3,713.16 | New | - | - |